Home / Brands / Samsung Bioepis

Samsung Bioepis Recalls

1 recall on record · November 5, 2025 to November 5, 2025 · Drugs

November 5, 2025DrugsFDA

Samsung Bioepis Co., Ltd. recalls HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for

Hazard: Lack of Assurance of Sterility.

Samsung Bioepis Recalls | RecallWatchUSA